Log in
Enquire now

List of RAPT Therapeutics patents

List of RAPT Therapeutics patents
List of ELIIY Power Co., Ltd. patents
List of Opko Health, Inc. patents
List of Marquette University patents
List of companies in Providence Strategic Growth's investment portfolio
List of companies in Ringleader Ventures's investment portfolio
Patents where
Current Assignee
Name
is
RAPT TherapeuticsRAPT Therapeutics
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 7356440 Method and business process for the estimation of erosion costs in assemble-to-order manufacturing operations

Patent 7356440 was granted and assigned to Rapt on April, 2008 by the United States Patent and Trademark Office.

RAPT Therapeutics
RAPT Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
7356440
April 8, 2008
‌
US Patent 7398221 Method and apparatus for component plan analysis under uncertainty

Patent 7398221 was granted and assigned to Rapt on July, 2008 by the United States Patent and Trademark Office.

RAPT Therapeutics
RAPT Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
7398221
July 8, 2008
‌
US Patent 7693762 Method and apparatus for utility pricing analysis

Patent 7693762 was granted and assigned to RAPT Therapeutics on April, 2010 by the United States Patent and Trademark Office.

RAPT Therapeutics
RAPT Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
7693762
April 6, 2010
‌
US Patent 7249049 Method and business process for the estimation of mean production for assemble-to-order manufacturing operations

Patent 7249049 was granted and assigned to Rapt on July, 2007 by the United States Patent and Trademark Office.

RAPT Therapeutics
RAPT Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
7249049
July 24, 2007
‌
US Patent 7536311 Method and apparatus for estimation of component gating and shortage risk in manufacturing operations

Patent 7536311 was granted and assigned to Rapt on May, 2009 by the United States Patent and Trademark Office.

RAPT Therapeutics
RAPT Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
7536311
May 19, 2009
‌
US Patent 11384064 Chemokine receptor modulators and uses thereof

Patent 11384064 was granted and assigned to Rapt on July, 2022 by the United States Patent and Trademark Office.

RAPT Therapeutics
RAPT Therapeutics
RAPT Therapeutics
RAPT Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
11384064
July 12, 2022
‌
US Patent 10589235 Bubble maker

Patent 10589235 was granted and assigned to RAPT Therapeutics on March, 2020 by the United States Patent and Trademark Office.

RAPT Therapeutics
RAPT Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
10589235
March 17, 2020
‌
US Patent 11918582 Pyrazole pyrimidine compounds and uses thereof

Patent 11918582 was granted and assigned to RAPT Therapeutics on March, 2024 by the United States Patent and Trademark Office.

RAPT Therapeutics
RAPT Therapeutics
RAPT Therapeutics
RAPT Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
11918582
March 5, 2024
‌
US Patent 12006318 Crystalline forms of C-C chemokine receptor type 4 antagonist and uses thereof

Patent 12006318 was granted and assigned to RAPT Therapeutics on June, 2024 by the United States Patent and Trademark Office.

RAPT Therapeutics
RAPT Therapeutics
RAPT Therapeutics
RAPT Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
12006318
June 11, 2024
9 results
0 selected
9 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us